Affective and cognitive behavior in the alpha-galactosidase A deficient mouse model of Fabry disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: PLoS ONE 12(6):e0180601. DOI: 10.1371/journal.pone.0180601
- Event
-
Veröffentlichung
- (where)
-
Würzburg
- (who)
-
Universität Würzburg
- (when)
-
2019
- Creator
- URN
-
urn:nbn:de:bvb:20-opus-170745
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hofmann, Lukas
- Karl, Franziska
- Sommer, Claudia
- Üçeyler, Nurcan
- Universität Würzburg
Time of origin
- 2019
Other Objects (12)
The α-galactosidase A deficient mouse as a model for Fabry disease and the effect of Gb3 depositions on peripheral nociceptive ion channel function
Comprehensive and differential long-term characterization of the alpha-galactosidase A deficient mouse model of Fabry disease focusing on the sensory system and pain development
MoKon - ein Ansatz zur wissensbasierten Konfiguration von Variantenerzeugnissen
The New Palace in Sans Souci Park
Natural course of Guillain-Barré syndrome
The New Entity of Paranodopathies: A Target Structure with Therapeutic Consequences
The impact of inflammation, hypoxia, and vasculopathy on pain development in the α-galactosidase A mouse model of Morbus Fabry
Affective and cognitive behavior is not altered by chronic constriction injury in B7-H1 deficient and wildtype mice
Behandlungswechsel von Agalsidase beta zu Agalsidase alfa bei Morbus Fabry
Charakterisierung von Spinalganglienneuronen im alpha-Galaktosidase A-defizienten Maus-Modell des M. Fabry
High-Dose Capsaicin for the Treatment of Neuropathic Pain: What We Know and What We Need to Know
Nachweis und Analyse von Phospho-Alpha-Synuclein-Ablagerungen in Hautnerven von Patienten mit Morbus Parkinson oder Multisystematrophie
The α-galactosidase A deficient mouse as a model for Fabry disease and the effect of Gb3 depositions on peripheral nociceptive ion channel function
Comprehensive and differential long-term characterization of the alpha-galactosidase A deficient mouse model of Fabry disease focusing on the sensory system and pain development
MoKon - ein Ansatz zur wissensbasierten Konfiguration von Variantenerzeugnissen
The New Palace in Sans Souci Park
Natural course of Guillain-Barré syndrome
The New Entity of Paranodopathies: A Target Structure with Therapeutic Consequences
The impact of inflammation, hypoxia, and vasculopathy on pain development in the α-galactosidase A mouse model of Morbus Fabry
Affective and cognitive behavior is not altered by chronic constriction injury in B7-H1 deficient and wildtype mice
Behandlungswechsel von Agalsidase beta zu Agalsidase alfa bei Morbus Fabry
Charakterisierung von Spinalganglienneuronen im alpha-Galaktosidase A-defizienten Maus-Modell des M. Fabry
High-Dose Capsaicin for the Treatment of Neuropathic Pain: What We Know and What We Need to Know
Nachweis und Analyse von Phospho-Alpha-Synuclein-Ablagerungen in Hautnerven von Patienten mit Morbus Parkinson oder Multisystematrophie
The α-galactosidase A deficient mouse as a model for Fabry disease and the effect of Gb3 depositions on peripheral nociceptive ion channel function
Comprehensive and differential long-term characterization of the alpha-galactosidase A deficient mouse model of Fabry disease focusing on the sensory system and pain development
MoKon - ein Ansatz zur wissensbasierten Konfiguration von Variantenerzeugnissen
The New Palace in Sans Souci Park
Natural course of Guillain-Barré syndrome
The New Entity of Paranodopathies: A Target Structure with Therapeutic Consequences
The impact of inflammation, hypoxia, and vasculopathy on pain development in the α-galactosidase A mouse model of Morbus Fabry
Affective and cognitive behavior is not altered by chronic constriction injury in B7-H1 deficient and wildtype mice
Behandlungswechsel von Agalsidase beta zu Agalsidase alfa bei Morbus Fabry
Charakterisierung von Spinalganglienneuronen im alpha-Galaktosidase A-defizienten Maus-Modell des M. Fabry
High-Dose Capsaicin for the Treatment of Neuropathic Pain: What We Know and What We Need to Know